BRIEF published on 07/11/2024 at 15:05, 1 year 4 months ago AcceleDev Chemical LLC Opens Advanced 5,000-Sq.-Ft. R&D/GMP Facility in Cranbury, NJ Drug Development New Jersey AcceleDev Chemical LLC R&D/GMP Facility Pharmaceutical Synthesis
BRIEF published on 07/11/2024 at 15:05, 1 year 4 months ago AcceleDev Chemical LLC ouvre une usine avancée de 5 000 pieds carrés. Installation de R&D/BPF à Cranbury, NJ New Jersey Développement De Médicaments AcceleDev Chemical LLC Installation De R&D/BPF Synthèse Pharmaceutique
PRESS RELEASE published on 07/11/2024 at 15:00, 1 year 4 months ago AcceleDev Chemical LLC Unveils New 5,000-Sq.-Ft. R&D/GMP Production Site in Cranbury, New Jersey, USA AcceleDev Chemical LLC announces the opening of a new state-of-the-art R&D and GMP production facility in Cranbury, NJ, enhancing capabilities in pharmaceutical solutions R&D AcceleDev Chemical LLC GMP Production Facility Pharmaceutical Solutions Cranbury NJ
Published on 12/05/2025 at 02:35, 4 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 25 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 55 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 11 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 40 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
